You are here: Industry Insights > T cells

News List

Study identifies immune cells involved in protection against COVID-19 expresspharma
June 29, 2020
A study, published in the journal Science Immunology, assessed T cells from 10 COVID-19 patients under intensive care treatment.
CAR macrophages go beyond T cells to fight solid tumors worldpharmanews
March 25, 2020
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors.
Thyas Obtains Exclusive Rights to Manufacture Induced Pluripotent Stem Cells-Derived Killer T Cells for Autologous Immunotherapy pharmafocusasia
January 21, 2019
Thyas Co. Ltd. (Thyas) signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of induced pluripotent stem (iPS) cell related-patents from Kyoto University.....
Certain brain tumours could respond to immunotherapy pharmaphorum
December 12, 2018
Some brain tumours may respond to immunotherapy after all, according to a new study.So far, brain tumours have been resistant to immunotherapy drugs because.....
Gilead’s Kite bags option to buy gamma delta startup Gadeta fiercebiotech
July 23, 2018
Gilead’s Kite Pharma has snagged an option to buy gamma delta T-cell receptor (TCR) startup Gadeta. The deal sees Kite take a stake in Gadeta and commit to milestones tied to the progress of oncology candidates.
CAR-T 2.0? A split, universal and programmable system fiercebiotech
April 27, 2018
Recent FDA approvals have validated the use of chimeric antigen receptor T cells (CAR-Ts) to fight blood cancers...
T cells found to ‘acquire knowledge’ to take fight to metastatic cancer pharmafile
May 18, 2017
T cells are widely known as being crucial in the fight against cancer within the body but little was known, previously, about what happened after their role was after infiltrating a tumour.
Novel ‘barcode’ tracking of T cells in immunotherapy patients identifies likely cancer-killers firstwordpharma
February 28, 2017
Fred Hutch scientists link improved treatment responses with offspring of rare T cells

Previous page 1 2 Next page